Latest Health stories from Life.
Strategic angle: Will the FDA’s regulatory policies, particularly for rare-disease drugs, shift in the wake of Vinay Prasad’s imminent departure?
This KFF survey examines the cost concerns and coverage changes experienced by ACA Marketplace enrollees in 2025 following the expiration of enhanced benefits.
Strategic angle: Nursing homes misuse antipsychotic drugs for dementia patients, disguising the practice as schizophrenia treatment, a watchdog finds.
Strategic angle: Adam Sherwat, the director of the Office of Infectious Diseases in the FDA’s Center for Drug Evaluation and Research, is leaving the agency.
Strategic angle: The Covid-19 pandemic's early death toll was much higher than the official U.S. count, according to a new study that spotlights dramatic disparities in the uncounted deaths.
Strategic angle: A new bill aims to mandate drugmakers and patient groups to reveal their connections to disease awareness initiatives.
Strategic angle: A mouse study shows CAR-T cells can be engineered in vivo with precise gene editing, a potential breakthrough that could cut costs and expand access.
Strategic angle: STAT's AI Prognosis takes a closer look at how the U.S. moonshot agency for health research is developing AI agents for deployment in hospitals.
Strategic angle: A Huntington's researcher treads lightly into the UniQure-FDA fray, J&J wins approval for a first-of-its kind psoriasis pill, and more in today's Readout newsletter.
Strategic angle: JAMA Cardiology study highlights the increased heart disease risk associated with premature menopause, particularly among Black women.
Strategic angle: As the Trump administration goes after fraud in health care, advocates say the disability community feels singled out.
Strategic angle: U.S. health officials claim TrumpRx offers Americans the world’s lowest prices on prescription drugs, but a new analysis found that is not true.
Strategic angle: The HHS has made reducing animal testing a priority over the past year.
Strategic angle: Test your knowledge on health insurance with this 10-question quiz to make informed decisions about your coverage.
Strategic angle: Johnson & Johnson's new daily psoriasis pill offers benefits comparable to injectable treatments, potentially disrupting a multibillion-dollar market.
Strategic angle: A new study reveals that opioid smokers are four times more likely to suffer severe burns compared to those who inject drugs.
Strategic angle: Hallway beds cut into the bones that sustain emergency medicine, shaving away layers of moral tenets and high standards.
Strategic angle: Leaving her career as a surgeon, Frances Mei Hardin writes, “was the beginning of a life I actually wanted.”
Strategic angle: Jay Bhattacharya assures House appropriators that the NIH will utilize its entire budget by the end of the fiscal year 2026.
Strategic angle: This fact sheet identifies key U.S. government global health positions and officials.